Skip to main content

Home/ MaRS/ Group items tagged technology

Rss Feed Group items tagged

Sarah Hickman

Amazon.com: Technology Ventures: From Idea to Enterprise (9780071259231): Richard C. Do... - 0 views

  •  
    "Technology Ventures" is the first textbook to thoroughly examine a global phenomenon known as "technology entrepreneurship". Now in its second edition, this book integrates the most valuable entrepreneurship and technology management theories from some of the world's leading scholars and educators with current examples of new technologies and an extensive suite of media resources. Dorf and Byers's comprehensive collection of action-oriented concepts and applications provides both students and professionals with the tools necessary for success in starting and growing a technology enterprise. "Technology Ventures" details the critical differences between scientific ideas and true business opportunities.
Assunta Krehl

Pharmafocus.com - 0 views

  • Canada has always had to fight hard to attract talent and investment
  • MaRS Vital to Toronto's life sciences vision is MaRS (derived from Medical and Related Sciences) a non-profit organisation and business centre located in the heart of the city. Its core function is as a biotech incubator and business park, known as MaRS Discovery District. The venture was first established in 2000 to help foster and accelerate the growth of successful Canadian businesses and, after some uncertain times, it is now gathering momentum. A separate technology transfer office, MaRS Innovation, has also been established that, it is hoped, can be a world beater in its own right (see Turning good ideas into world beaters below). The location of the MaRS building in central Toronto is important, as it is just a stone's throw away from an existing cluster of universities and academic hospitals. MaRS has many links with other research-based organisations, including collaborations with three local universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS occupies the Old Toronto general hospital, where insulin was first discovered by Best and Banting in 1921 and then developed for use in human trials. The 21st Century organisation can build on this heritage in patient-focused discovery and development. Formerly the head of venture capital firm Primaxis, Ilse Treurnicht is chief executive of MaRS Discovery District. She acknowledges the crisis in venture capital funding, and says Canada's sector has always had less access funds through this route than other countries. This is one of the drivers behind the search for a new approach. Treurnicht says the old models of building biotech and life sciences businesses have to be discarded, as they have failed to build companies with critical mass. She says MaRS' new 'Convergence Innovation' strategy of bringing science, capital and business together will pay off.
  • "We call our strategy 'Convergence Innovation' and what we are trying to do is move away from the old linear model of academics struggling in their spare time to build companies or entrepreneurs doing this in a very incremental way."It takes time and it has many risk points along the way. So using this Convergence centre model to create a much more dynamic organisation which can help accelerate good ideas towards the commercialisation." But she says Canada's geography and demographics are always going to be a challenge. "This is a very large country with a small population. If you think in terms of clusters and hub regions, Canada's business hubs are separated geographically, and there is not much in between in terms of people."That means we can't try to be a little United States, because we just won't show up on the radar. We have to take a different approach. We have to think about collaboration as our potential competitive advantage - that means using networks and associations to solve problems and build businesses."So as new opportunities emerge, we can take them to market faster and hopefully with a higher success rate." The centre currently accommodates numerous start up companies, as well as those providing legal and financial services to them. AstraZeneca and GlaxoSmithKline also have offices on site. In all, MaRS provides mentoring for over 200 different companies across Ontario, and runs courses on entrepreneurship and preparing products for market.
  • ...7 more annotations...
  • Transition Therapeutics is one of the companies based at MaRS, and is an example of a biopharmaceutical company that is taking a new approach to the science and business of drug development.
  • Now Toronto's MaRS Innovation (MI) has been launched to try to guide and accelerate these promising ideas out of the wilderness and onto the market. MI is a not-for-profit technology transfer company that will channel all the best ideas to come out of Toronto's renowned academic centres. In the Toronto and Ontario area there were between 14-16 different technology transfer offices in the different institutions, and MaRS Innovation resolved to bring these interests together into a single entity after industry partners told them it was an inefficient way to do business. Bringing together the different institutions under one umbrella organisation has been an arduous task for MaRS, but the reward could be considerable for all parties. MI now oversees probably the largest intellectual property pipeline of its kind, representing about $1 billion in annual research spending. This means MI will be a unified route for all of Toronto's academics and their institutions when they want to develop and commercialise a bright idea. Most importantly, investors from industry who are looking to collaborate will now be able to deal with just organisation and one IP process. MI will cover patentable ideas across a broad range of areas, and not just life sciences - the discovery pipeline in physical sciences, information and communication technology, and green technology ('cleantech') will all be funnelled through MI. MI now represents three universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS Innovation, with support from MaRS and BioDiscovery Toronto, will advance commercialisation through industry partnerships, licensing and company creation.
  • ts chief executive is Dr Rafi Hofstein. Hofstein has been headhunted from Israel where he was chief executive of Hadasit, the technology transfer company of the Hadassah Medical Organization in Jerusalem and chair of the publicly-traded company Hadasit BioHolding. He brings this considerable experience in technology transfer to what he thinks is a groundbreaking enterprise."MaRS Innovation is a unique global initiative, and I must commend the institutional leaders in Toronto for pulling this innovation powerhouse together to strengthen commercialisation output." He adds: "I believe this is going to modernise the whole notion of tech transfer." He says the scale and diversity of MaRS Innovation's remit puts it into a league of its own. Other research clusters elsewhere in the world have attempted similar projects before, but have been thwarted by the difficulty in bringing parties together. MaRS Innovation will also help launch and grow new spin-off companies and incubate them for 2-3 years to ensure a strong commercial footing. Hofstein says MI will also fund proof of concept trials which will persuade major pharma companies to invest in their development.
  • MI has just announced its first two commercialisation deals with academic partners in the city. The first is with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital to develop stem cell from umbilical cords to treat cardiovascular disease, diabetes and neurological disorders. "With the Toronto area identified as a world-leading cluster in stem cell research, we are extremely excited to have identified this technology as our first commercialisation opportunity," said Dr Hofstein.
  • "Our partnership with MaRS Innovation on developing methods for using stem cells for diseases such as diabetes will allow us to work towards advancing care for these critical conditions."
  • The second collaboration is between MI and The University of Toronto (U of T) and involves a novel sustained release formulation of nitric oxide (NO) for applications in wound healing, including diabetic ulcers. "There are 300 million diabetics worldwide, of which some 15% develop troublesome foot ulcers. This wound healing technology is extremely exciting, making it an early commercialisation opportunity that MaRS Innovation has identified as being a potential win for some 45 million diabetics globally," said Dr Hofstein.
  • "This is one of many new commercialisation ventures that will be initiated by MaRS Innovation, our partner in commercialisation of research with 13 other academic institutions across the Greater Toronto Area," said Paul Young, U of T's vice-president, Research. "We at U of T are delighted that this innovation from Dr Lee will be taken to the marketplace to the benefit of society and the economy of Ontario and Canada." By aggregating the leading edge science of its institutional members and being a one-stop commercialisation centre for industry, entrepreneurs and investors, MI could really help put Toronto and Canada on the map."MaRS Innovation is deeply committed to facilitating strategic research collaborations with industry partners, strengthening the innovation capacity of Canadian industry through adoption of new technologies, and launching a new generation of robust, high-growth Canadian companies that will become global market leaders," added Dr Hofstein. "We look forward to working closely with all of our institutional members and to continue to jointly announce exciting commercial opportunities."
  •  
    Canada has always had to fight hard to attract talent and investment. As stated in Pharmafocus.com, "MaRS Discovery District helps to foster and accelerate the growth of successful Canadian businesses." MaRS Innovation has also been launched to accelerate ideas onto the market.
Assunta Krehl

Sangoma Ranked Among Fastest Growing Technology Companies in Canada in Deloitte Technol... - 0 views

  •  
    Sangoma® Technologies Corporation a leading supplier of hardware and software enabling server-based voice and data communication applications, announced today that the company has ranked 40th among the Deloitte Technology Fast 50TM. MaRS is a program sponsor for the Deloitte Technology Fast 50TM. Oct 5, 2009
Sarah Hickman

SDTC Application Advice - 0 views

  •  
    Clean Tech Funding\n\nIf you have a new, innovative technology that helps address climate change or promotes clean water, land or air, then Sustainable Development Technology Canada (SDTC) wants to hear from you.(\n\nSDTC supports late-stage development and pre-commercial demonstration of clean technologies by Canadian companies.( (The Statement of Interest (SOI) is an initial application used for preliminary screening and is subject to a competitive review process by SDTC and a panel of independent experts. ( (Applications are evaluated on the basis of their fit with SDTC's mandate, selection criteria, and the quality of technology, marketing and business capabilities. ( (IMPORTANT - Prior to submitting an application and to ensure a good fit:\n\n 1. First review the "Application Advice" section and subsections on SDTC's web site, starting at http://www.sdtc.ca/en/funding/advice/index.htm.\n 2. Register for one of their free online webinars or workshop to learn more - see http://sdtc.ca/en/news/events/200803-61120.htm for details. \n 3. Then discuss your proposed project with one of their Applications Managers.\n
Assunta Krehl

Clean energy comes to the coffee table - Clean Break - 0 views

  • Is green, renewable energy a sexy enough topic to be the centrepiece of a coffee table book? Tom Rand, who leads cleantech development at Toronto’s MaRS Centre, believes so
  • a book that will expose a broader section of the population to the issues, technologies and opportunities around renewable energy. Rand has written a soon-to-be-released book called Kick The Fossil Fuel Habit: 10 Clean Technologies To Save Their World.
  • This is an accessible package, cleverly assembled and pleasant to look at, while at the same time making it enjoyable to learn about the technologies that, while seemingly “alternative” or “new” today, are destined to become a dominant and permanent way of energizing future generations and the economies that support them.
  • ...1 more annotation...
  • The plan is to distribute it through mainstream outlets such as Starbucks to coincide with the big climate-change conference coming up in December in Copenhagen. It will be released in October.
  •  
    Tom Rand, MaRS Practice Lead in Cleantech, will be releasing his book called Kick The Fossil Fuel Habit: 10 Clean Technologies To Save Their World in October 2009. This book will expose the broader population to the issues, technologies and opportunities around renewable energy.
  •  
    Tom Rand, MaRS Practice Lead in Cleantech, will be releasing his book called Kick The Fossil Fuel Habit: 10 Clean Technologies To Save Their World in October 2009. This book will expose the broader population to the issues, technologies and opportunities around renewable energy. Aug 30, 2009
Assunta Krehl

MaRS Innovation selects umbilical cord stem cell technology from Samuel Lunenfeld Resea... - 0 views

  • MaRS Innovation and the Samuel Lunenfeld Research Institute of Mount Sinai Hospital are pleased to announce that they have entered into an agreement to collaboratively initiate commercialization of an umbilical cord stem cell technology for potential treatment in cardiovascular disease, diabetes and neurological disorders.
  • With the Toronto area identified as a world-leading cluster in stem cell research, we are extremely excited to have identified this technology as our first commercialization opportunity,” said Dr. Rafi Hofstein, President and CEO of MaRS Innovation.
  • MaRS Innovation, along with the inventors and Mount Sinai, will initially focus on the diabetes application for the technology, as research has demonstrated that these cells uniquely secrete insulin in response to glucose, thereby mimicking the “normal” physiological state.
  • ...5 more annotations...
  • The technology – invented by Mount Sinai scientists Dr. Ian Rogers and Dr. Robert Casper – offers a proprietary method to create multi-potent stem cells (MPSCs) from human umbilical cord blood.
  • With MaRS Innovation's participation, we are optimistic we will succeed."
  • Our partnership with MaRS Innovation on developing methods for using stem cells for diseases such as diabetes will allow us to work towards advancing care for these critical conditions." With the launch of this first exciting opportunity, MaRS Innovation has embarked on a journey to transform the Toronto-based research enterprise into a successful commercialization cluster.
  • MaRS Innovation is building its own internal infrastructure to support intellectual property and market due diligence to identify the most promising commercial opportunities. MaRS Innovation is dedicated to converting the outstanding science of its member institutions into products and services, making a significant contribution to Canada’s future economic outlook and the quality of life for Canadians and others around the world
  • “We are deeply committed to creating a powerful engine for commercialization that brings together an experienced team to identify and validate market opportunities, develop technologies to market requirements and build the linkages that will advance the exceptional research of all of our institutional members,” added Dr. Hofstein. “We look forward to announcing additional technologies to add to our pipeline over the next several weeks.”
  •  
    MaRS Innovation and the Samuel Lunenfeld Research Institute of Mount Sinai Hospital are announce that they have entered into an agreement to collaboratively initiate commercialization of an umbilical cord stem cell technology for potential treatment in cardiovascular disease, diabetes and neurological disorders.
Assunta Krehl

Research improves performance of next-generation solar cell technology - Physorg - Sept... - 0 views

  •  
    As stated in the Psych org "Researchers from the University of Toronto (U of T), the King Abdullah University of Science & Technology (KAUST) and Pennsylvania State University (Penn State) have created the most efficient solar cell ever made based on collodial-quatum-dots...a technology licensing agreement has been signed by U of T and KAUST, brokered by MaRS Innovations (MI), which will will enable the global commercialization of this new technology." 
Assunta Krehl

Research Improves Performance of Next-Generation Solar Cell Technology - Product Design... - 0 views

  •  
    As stated in Product Design and Development "Researchers from the University of Toronto (U of T), the King Abdullah University of Science & Technology (KAUST) and Pennsylvania State University (Penn State) have created the most efficient solar cell ever made based on collodial-quatum-dots...a technology licensing agreement has been signed by U of T and KAUST, brokered by MaRS Innovations (MI), which will will enable the global commercialization of this new technology." 
Assunta Krehl

Research improves performance of next-generation solar cell technology - R&D Magazine -... - 0 views

  •  
    As stated in Rx&D Magazine, "Researchers from the University of Toronto (U of T), the King Abdullah University of Science & Technology (KAUST) and Pennsylvania State University (Penn State) have created the most efficient solar cell ever made based on collodial-quatum-dots...a technology licensing agreement has been signed by U of T and KAUST, brokered by MaRS Innovations (MI), which will will enable the global commercialization of this new technology." 
Assunta Krehl

Waterloo spin-off wins recognition for smarter alloy technology - Canadian Manufacturin... - 0 views

  •  
    Waterloo University spinoff, Innovative Processing Technologies (IPT) a MaRS Tenant, has been recognized for its Multiple Memory Material (MMM) technology.
Assunta Krehl

Green meets high tech-MaRS - Tech Media - 0 views

  •  
    Energy conservation with IP based technology is creating surprising forms of convergence in buildings. Mention of MaRS Discovery District winning the Intelligent Building of teh Year award for its inventive use of technology.
  •  
    Energy conservation with IP based technology is creating surprising forms of convergence in buildings. Mention of MaRS Discovery District winning the Intelligent Building of the Year award for its inventive use of technology. Sept 13, 2007
Assunta Krehl

U of T-led research improves performance of next-generation solar cell technology - Sci... - 0 views

  •  
    As stated in the Science Daily "Researchers from the University of Toronto (U of T), the King Abdullah University of Science & Technology (KAUST) and Pennsylvania State University (Penn State) have created the most efficient solar cell ever made based on collodial-quatum-dots...a technology licensing agreement has been signed by U of T and KAUST, brokered by MaRS Innovations (MI), which will will enable the global commercialization of this new technology." 
Assunta Krehl

U of T Led Research Improves Performance of Next-Generation Solar Cell Techno... - 0 views

  •  
    As stated in Harold Doan and Associates Ltd, "Researchers from the University of Toronto (U of T), the King Abdullah University of Science & Technology (KAUST) and Pennsylvania State University (Penn State) have created the most efficient solar cell ever made based on collodial-quatum-dots...a technology licensing agreement has been signed by U of T and KAUST, brokered by MaRS Innovations (MI), which will will enable the global commercialization of this new technology." 
Assunta Krehl

Nanotechnology Now - Press Release: "U of T-led research improves performance of next-g... - 0 views

  •  
    As stated in Nanotechnology Now, "Researchers from the University of Toronto (U of T), the King Abdullah University of Science & Technology (KAUST) and Pennsylvania State University (Penn State) have created the most efficient solar cell ever made based on collodial-quatum-dots...a technology licensing agreement has been signed by U of T and KAUST, brokered by MaRS Innovations (MI), which will will enable the global commercialization of this new technology." 
Assunta Krehl

U of T-led research improves performance of next-generation solar cell technology - Inn... - 0 views

  •  
    As stated in the Innovations Report "Researchers from the University of Toronto (U of T), the King Abdullah University of Science & Technology (KAUST) and Pennsylvania State University (Penn State) have created the most efficient solar cell ever made based on collodial-quatum-dots...a technology licensing agreement has been signed by U of T and KAUST, brokered by MaRS Innovations (MI), which will will enable the global commercialization of this new technology." 
Assunta Krehl

DeckChair to provide Seneca College with e-learning assessment technology - Canada News... - 0 views

  •  
    Seneca College awarded $2.3 million in federal research funding to improve aviation education in Canada.DeckChair Learning Systems, an online learning company, will provide e-learning and assessment technology to Seneca's renowned School of Aviation and Flight Technology research team. The multi-year project will investigate innovative simulation technologies to train and test pilots. Dec 1, 2009
Assunta Krehl

Notable Canadians in Digital Media & Technology - Webslinger - July 1, 2012 - 1 views

  •  
    Glen Farrelly, a blogger, explores the digital media and technology innovations and their Canadian connections. Dr Ilse Treurnicht, CEO, MaRS Discovery District is listed as a significant contributor to the digital culture and technology.
Assunta Krehl

Ryerson's Professor Recognized by MIT Technology Review's TR35 Listing of the World's T... - 0 views

  •  
    Dr. Hossein Rahnama who is known for his groundbreaking work in context-aware and cloud computing platforms has been recognized as part of MIT's Technology Review magazine's 2012 list of the world's top innovators under the age of 35. Dr. Hossein Rahnama founded Flybits, which is a spin-off of Ryerson University and is supported by Digital Media Zone and MaRS Innovation.
Assunta Krehl

MaRS clients clean up at Deloitte Technology Fast 50 Awards - Canada Newswire - 0 views

  •  
    Four Ontario start-up companies working with MaRS advisory services are among those recognized by this year's Deloitte Technology Fast 50(TM) program, Canada's pre-eminent technology awards. These companies were Aeryon Labs Inc., Bayalink Solutions Corp., Real Tech Inc. and Vive Nano. Oct 1, 2009
Assunta Krehl

Clean Technologies Will Drive Ontario's Future Economic Prosperity - Sustainable Develo... - 0 views

  • Ontario's clean technology industry is poised for growth, and is comprised of companies that manufacture, develop and sell competitive products. Despite this promise, these companies face key challenges in becoming globally competitive - including lack of growth capital, weak domestic demand, and a small pool of management experienced in product commercialization.
  • Ogilvy Renault LLP, MaRS Discovery District, Blake, Cassels & Graydon LLP, Export Development Canada, RBC, Department of Foreign Affairs and International Trade, Ontario BioAuto Council, TMX Group Inc., Canada's Venture Capital & Private Equity Association, National Angel Capital Organization, XPV Capital and Investeco Capital.
  •  
    Ontario's clean technology industry is poised for growth, and is comprised of companies that manufacture, develop and sell competitive products. Cleantech companies need to gain greater globalization and increase their product commercialization.
  •  
    Ontario's clean technology industry is poised for growth, and is comprised of companies that manufacture, develop and sell competitive products. Cleantech companies need to gain greater globalization and increase their product commercialization. Feb 17, 2009
1 - 20 of 371 Next › Last »
Showing 20 items per page